Page last updated: 2024-09-05

kwd 2131 and isoproterenol

kwd 2131 has been researched along with isoproterenol in 1 studies

Compound Research Comparison

Studies
(kwd 2131)
Trials
(kwd 2131)
Recent Studies (post-2010)
(kwd 2131)
Studies
(isoproterenol)
Trials
(isoproterenol)
Recent Studies (post-2010) (isoproterenol)
1612030,7808032,640

Protein Interaction Comparison

ProteinTaxonomykwd 2131 (IC50)isoproterenol (IC50)
Beta-2 adrenergic receptorHomo sapiens (human)0.246
Beta-1 adrenergic receptorHomo sapiens (human)0.333
Beta-2 adrenergic receptorRattus norvegicus (Norway rat)0.2125
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)1.77
Beta-1 adrenergic receptorRattus norvegicus (Norway rat)0.2125
Beta-3 adrenergic receptorRattus norvegicus (Norway rat)0.2125
Beta-2 adrenergic receptorCanis lupus familiaris (dog)0.6667

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pegelow, KO; Persson, CG; Sörenby, L; Strandberg, K1

Other Studies

1 other study(ies) available for kwd 2131 and isoproterenol

ArticleYear
Anti-anaphylactic and bronchodilating action of a beta-adrenoceptor stimulator, KWD 2131, in human lung tissue.
    Allergy, 1979, Volume: 34, Issue:4

    Topics: Adrenergic beta-Agonists; Allergens; Anaphylaxis; Bronchi; Bronchodilator Agents; Ethanolamines; Histamine Release; Humans; In Vitro Techniques; Isoproterenol; Lung; Pollen; Terbutaline

1979